ArticleCellular oncology (Dordrecht, Netherlands)2016

Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma.

Yushi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.